Hospitals in north carolina reported resistance ...

Klebsiella pneumonia

Klebsiella pneumonia is a common form of Gram-negative bacteria in the mouth, skin and intestine. Infection often suffer those with weakened immune systems. Opportunist pathogens, Klebsiella pneumonia

is widespread in hospitals and difficult fight. The most significant source of infection is patient contact with feces and contaminated instruments. Even with antibiotic therapy, it has a high mortality by about 50 percent, and nearly 100 percent for persons with alcoholism and bacteremia. Urinary tract infections often caused by Klebsiella pneumonia

, where he is second in prevalence of E. coli. The first documented history of antimicrobial resistance in bacteria Klebsiella pneumonia in strattera no prescritpion 1996. Hospitals in North Carolina reported resistance to a class of antibiotics known as karbapenemy. Since

Klebsiella pneumonia carbapenemase (KPC), outbreaks were reported in Israel, South America, the Caribbean, Scotland and China. In the U.S., 24 states reported cases of PDA. New York and New Jersey remain a hotbed SSKP to 37 percent

Klebsiella pneumonia isolates identified as SSKP (Source: Drug Benefits Trends). Opportunities are limited for the treatment of bacteria producing carbapenemases Klebsiella pneumonia. Production carbapen-emase bacteria leads to resistance to multiple antibiotics, including penicillins, cephalosporins, and aztreonam karbapenemy. Resistance to fluoroquinolones, trimethoprim / sulfamethoxazole, and aminoglycosides are also frequently observed. In vitro studies consistently show progress against the CCP and e-Polymyxin antibiotics Tigecycline, however, these procedures carry a narrow therapeutic indices and can be toxic to patients. With such strong resistance of bacteria to antibiotics so much fast rapid detection and identification of Klebsiella pneumonia

carbapenemases is crucial to protect patients from exposure and to save lives. This becomes a problem when the result from ordinary culture Petit may take up to 24 hours. In contrast, NanoLogix technology reduces the time waiting in the living cell

Klebsiella pneumonia detection and identification of microorganisms, only 6:00. This rapid detection and identification of viable Klebsiella pneumonia prevention epidemiology and infection control personnel for the presence of pathogenic bacteria to 40 percent faster than conventional culture Petri permit. In turn, this means that precautions to protect patients from risk groups can start as many as 18 hours faster. In addition to the protection of patients and improve public safety, a rapid detection and identification of CCP reduces the economic costs associated with the outbreak. Activities such as active tests diagnostic prevalence in areas of high risk and precautions when exposed infected patients is strongly recommended to enter into force when it detects

Klebsiella carbapenemases pneumonia. (Source: CDC). With more rapid detection of these measures can be greatly reduced or alleviated, saving time and money. .